Bourla did not define “at this stage.” But he could not have been referring to the moment of the interview. Pfizer was not making money on the vaccine at all in mid-2020. It was spending, as it moved the shot into a large clinical trial.
(Practically giving it away!)
SOURCE
Instead, Bourla appeared to mean the period in which Covid vaccine purchasing and distribution would be government-controlled and the shots offered globally to everyone for free — the “emergency” phase of the epidemic. Even J&J and AstraZeneca did not promise to sell their shots on a nonprofit basis forever.
In other words, Bourla appeared to say that for at least as long as the United States declared Covid an emergency, Pfizer would charge a “very nominal” price and make a “very marginal profit” on its vaccine.
About that.
(I DON’T MAKE AS MUCH MONEY AS PFIZER, BUT I STILL GOTTA CHARGE EVERY ONCE IN A WHILE) (2/?)
